{"id":"https://openalex.org/W1996748355","doi":"https://doi.org/10.1111/j.1471-4159.2004.02761.x","title":"Adenosine receptor\u2010mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N\u2010methyl\u2010 d \u2010aspartate receptor stimulation","display_name":"Adenosine receptor\u2010mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N\u2010methyl\u2010 d \u2010aspartate receptor stimulation","alternate_titles":[],"publication_year":2004,"publication_date":"2004-10-27","ids":{"openalex":"https://openalex.org/W1996748355","doi":"https://doi.org/10.1111/j.1471-4159.2004.02761.x","mag":"1996748355","pmid":"https://pubmed.ncbi.nlm.nih.gov/15525341"},"language":"en","primary_location":{"id":"doi:10.1111/j.1471-4159.2004.02761.x","doi":"https://doi.org/10.1111/j.1471-4159.2004.02761.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2004.02761.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1996748355"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074577811","display_name":"Davide Quarta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Davide Quarta","raw_affiliation_strings":["Preclinical Pharmacology Section, Behavioral Neuroscience Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology Section, Behavioral Neuroscience Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112013751","display_name":"Janusz Borycz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janusz Borycz","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050464958","display_name":"Marcello Solinas","orcid":"https://orcid.org/0000-0002-0664-5964","observed_orcids":["https://orcid.org/0000-0002-0664-5964"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcello Solinas","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103464890","display_name":"Kshitij A. Patkar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kshitij Patkar","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053098808","display_name":"J\u00f6rg Hockemeyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J\u00f6rg Hockemeyer","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032553363","display_name":"Francisco Ciruela","orcid":"https://orcid.org/0000-0003-0832-3739","observed_orcids":["https://orcid.org/0000-0003-0832-3739"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francisco Ciruela","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013842852","display_name":"Carme Llu\u00eds","orcid":"https://orcid.org/0000-0003-2869-6882","observed_orcids":["https://orcid.org/0000-0003-2869-6882"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carme Lluis","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043879414","display_name":"Rafael Franco","orcid":"https://orcid.org/0000-0003-2549-4919","observed_orcids":["https://orcid.org/0000-0003-2549-4919"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rafael Franco","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069741153","display_name":"Amina S. Woods","orcid":"https://orcid.org/0000-0002-9716-345X","observed_orcids":["https://orcid.org/0000-0002-9716-345X"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amina S. Woods","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110935158","display_name":"Steven R. Goldberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven R. Goldberg","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000524771","display_name":"Sergi Ferr\u00e9","orcid":"https://orcid.org/0000-0002-1747-1779","observed_orcids":["https://orcid.org/0000-0002-1747-1779"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergi Ferr\u00e9","raw_affiliation_strings":["National Institute on Drug Abuse, Bethesda, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute on Drug Abuse, Bethesda, United States","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":3.4032,"has_fulltext":false,"cited_by_count":131,"citation_normalized_percentile":{"value":0.9328215,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"91","issue":"4","first_page":"873","last_page":"880"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a1-receptor","display_name":"adenosine A1 receptor","score":0.8679999709129333},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dopamine-release","display_name":"dopamine release","score":0.9520000219345093},{"id":"https://openalex.org/keywords/nucleus-accumbens-shell","display_name":"nucleus accumbens shell","score":0.9129999876022339},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.8730000257492065},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8799999952316284},{"id":"https://openalex.org/keywords/msx-3","display_name":"MSX-3","score":0.7289999723434448},{"id":"https://openalex.org/keywords/apv","display_name":"APV","score":0.6830000281333923},{"id":"https://openalex.org/keywords/caffeine","display_name":"caffeine","score":0.6060000061988831},{"id":"https://openalex.org/keywords/cgs-21680","display_name":"CGS 21680","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cpt","display_name":"CPT","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6421248316764832},{"id":"https://openalex.org/C2780231331","wikidata":"https://www.wikidata.org/wiki/Q5010992","display_name":"CGS-21680","level":5,"score":0.5916767120361328},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.5426895618438721},{"id":"https://openalex.org/C2780634109","wikidata":"https://www.wikidata.org/wiki/Q18350222","display_name":"Adenosine receptor antagonist","level":5,"score":0.5283782482147217},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5183088183403015},{"id":"https://openalex.org/C2776552330","wikidata":"https://www.wikidata.org/wiki/Q1476178","display_name":"Nucleus accumbens","level":3,"score":0.5136722922325134},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.49487704038619995},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.4581567049026489},{"id":"https://openalex.org/C182683403","wikidata":"https://www.wikidata.org/wiki/Q14888579","display_name":"Adenosine A1 receptor","level":5,"score":0.4575963616371155},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.45277929306030273},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44914698600769043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43695658445358276},{"id":"https://openalex.org/C200170125","wikidata":"https://www.wikidata.org/wiki/Q969316","display_name":"Neurotransmission","level":3,"score":0.42006585001945496},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4068930447101593},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3700546622276306},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3643419146537781},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28387367725372314},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19828662276268005},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.09104406833648682}],"mesh":[{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002110","descriptor_name":"Caffeine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009714","descriptor_name":"Nucleus Accumbens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016202","descriptor_name":"N-Methylaspartate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018047","descriptor_name":"Receptors, Purinergic P1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018690","descriptor_name":"Excitatory Amino Acid Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058906","descriptor_name":"Purinergic P1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058908","descriptor_name":"Adenosine A2 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058915","descriptor_name":"Purinergic P1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058916","descriptor_name":"Adenosine A1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058917","descriptor_name":"Adenosine A2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1471-4159.2004.02761.x","doi":"https://doi.org/10.1111/j.1471-4159.2004.02761.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1471-4159.2004.02761.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:15525341","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15525341","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-00018045v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-00018045","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Neurochemistry, 2004, 91, pp.873-880. &#x27E8;10.1111/j.1471-4159.2004.02761.x&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W1515108121","https://openalex.org/W1529567719","https://openalex.org/W1551550807","https://openalex.org/W1603988625","https://openalex.org/W1753727899","https://openalex.org/W1838726298","https://openalex.org/W1965554200","https://openalex.org/W1965792012","https://openalex.org/W1967953985","https://openalex.org/W1971587049","https://openalex.org/W1972040137","https://openalex.org/W1972664525","https://openalex.org/W1973277048","https://openalex.org/W1974662037","https://openalex.org/W1979359907","https://openalex.org/W1980552142","https://openalex.org/W1985060592","https://openalex.org/W1989422254","https://openalex.org/W1992618805","https://openalex.org/W1998648994","https://openalex.org/W2000363595","https://openalex.org/W2011649118","https://openalex.org/W2017035445","https://openalex.org/W2017527385","https://openalex.org/W2018856591","https://openalex.org/W2020098765","https://openalex.org/W2022233762","https://openalex.org/W2023563819","https://openalex.org/W2025350700","https://openalex.org/W2029045430","https://openalex.org/W2029810520","https://openalex.org/W2034132865","https://openalex.org/W2035590629","https://openalex.org/W2036812929","https://openalex.org/W2038031154","https://openalex.org/W2038645044","https://openalex.org/W2043279327","https://openalex.org/W2044533253","https://openalex.org/W2052305668","https://openalex.org/W2052329772","https://openalex.org/W2053041281","https://openalex.org/W2053650795","https://openalex.org/W2056124241","https://openalex.org/W2057538799","https://openalex.org/W2060183829","https://openalex.org/W2061388579","https://openalex.org/W2065052465","https://openalex.org/W2066143615","https://openalex.org/W2068260754","https://openalex.org/W2068743427","https://openalex.org/W2073642047","https://openalex.org/W2089191547","https://openalex.org/W2090421493","https://openalex.org/W2095364366","https://openalex.org/W2106861254","https://openalex.org/W2138812507","https://openalex.org/W2145345810","https://openalex.org/W2203382348","https://openalex.org/W2415636866"],"related_works":["https://openalex.org/W2133531253","https://openalex.org/W1529567719","https://openalex.org/W2203382348","https://openalex.org/W1985667689","https://openalex.org/W31155113","https://openalex.org/W1948376754","https://openalex.org/W2015117347","https://openalex.org/W1515108121","https://openalex.org/W2023328664","https://openalex.org/W7098669184"],"abstract_inverted_index":{"Adenosine,":[0],"by":[1,163,186,199,215],"acting":[2],"on":[3,13,228,233],"adenosine":[4],"A(1)":[5,24,59,93,216,245],"and":[6,19,26,33,60,142,168,182,190,192,217,231],"A(2A)":[7,29,61,82,174,218,247],"receptors,":[8],"exerts":[9],"opposite":[10,225],"modulatory":[11,226],"roles":[12],"striatal":[14,39],"extracellular":[15,117],"levels":[16,118],"of":[17,23,28,38,52,58,75,119,124,138,206,212,235,244,254],"glutamate":[18,32,48,130,183],"dopamine,":[20],"with":[21,135,148,171],"activation":[22,27],"inhibiting":[25],"receptors":[30,62,219],"stimulating":[31],"dopamine":[34,120,160,181,196,207],"release.":[35],"Adenosine-mediated":[36],"modulation":[37,205],"dopaminergic":[40],"neurotransmission":[41,230],"could":[42],"be":[43],"secondary":[44,222],"to":[45,223],"changes":[46],"in":[47,50,63,69,107,116,121,209,250],"neurotransmission,":[49],"view":[51],"evidence":[53],"for":[54],"a":[55],"preferential":[56],"colocalization":[57],"glutamatergic":[64,229],"nerve":[65],"terminals.":[66],"By":[67],"using":[68],"vivo":[70],"microdialysis":[71],"techniques,":[72],"local":[73,136],"perfusion":[74,137],"NMDA":[76,151,236],"(3,":[77],"10":[78,89],"microm),":[79,90,100],"the":[80,91,102,122,125,149,172,210,213,242,251],"selective":[81,92,173],"receptor":[83,94,105,152,175,248],"agonist":[84],"2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine":[85],"(CGS":[86],"21680;":[87],"3,":[88],"antagonist":[95,106,153,176],"8-cyclopentyl-1,3-dimethylxanthine":[96],"(CPT;":[97],"300,":[98],"1000":[99,111],"or":[101],"non-selective":[103],"A(1)-A(2A)":[104],"vitro":[108],"caffeine":[109,191],"(300,":[110],"microm)":[112,158,179],"elicited":[113],"significant":[114],"increases":[115],"shell":[123,211],"nucleus":[126],"accumbens":[127],"(NAc).":[128],"Significant":[129],"release":[131,161,184,197,208],"was":[132],"also":[133],"observed":[134],"CGS":[139,165,187],"21680,":[140,166,188],"CPT":[141,167,189],"caffeine,":[143],"but":[144],"not":[145,194],"NMDA.":[146,200],"Co-perfusion":[147,170],"competitive":[150],"dl-2-amino-5-phosphonovaleric":[154],"acid":[155],"(APV;":[156],"100":[157],"counteracted":[159,180],"induced":[162,185,198],"NMDA,":[164],"caffeine.":[169,255],"MSX-3":[177],"(1":[178],"did":[193],"modify":[195],"These":[201],"results":[202,240],"indicate":[203],"that":[204],"NAc":[214],"is":[220],"mostly":[221],"their":[224],"role":[227,243],"depends":[232],"stimulation":[234],"receptors.":[237],"Furthermore,":[238],"these":[239],"underscore":[241],"vs.":[246],"antagonism":[249],"central":[252],"effects":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1996748355","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
